BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 4414534)

  • 1. Lymphocyte function and HL-A antigen frequency in gynecologic squamous cancer. A preliminary report.
    Twomey PL; Rogentine GN; Chretien PB
    Int Surg; 1974 Sep; 59(9):468-72. PubMed ID: 4414534
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of tumor antigens in gynecologic malignancies.
    Gall SA
    J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic response in gynecologic malignancy as demonstrated by the delayed hypersensitivity reaction: clinical correlations.
    Nalick RH; DiSaia PJ; Rea TH; Morrow MH
    Am J Obstet Gynecol; 1974 Feb; 118(3):393-405. PubMed ID: 4358924
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoembryonic antigen in cancer of the female reproductive system: its detection in serum by a microradioimmunoassay.
    Khoo SK; Mackay EV
    Aust N Z J Obstet Gynaecol; 1973 May; 13(2):107-13. PubMed ID: 4518714
    [No Abstract]   [Full Text] [Related]  

  • 5. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinoembryonic antigen in patients with gynecologic malignancies.
    DiSaia PJ; Haverback BJ; Dyce BJ; Morrow CP
    Am J Obstet Gynecol; 1975 Jan; 121(2):159-63. PubMed ID: 163585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of T-lymphocytes in patients with a gynecologic malignancy].
    Ressel M; Köhler G
    Zentralbl Gynakol; 1984; 106(17):1192-7. PubMed ID: 6333766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte cytotoxicity against allogeneic cultured cells in gynecologic malignancy.
    Arata T; Momozaki F; Kazuta M; Yamamoto H; Sekiba K
    Acta Med Okayama; 1979 Jun; 33(3):197-204. PubMed ID: 158947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological aspects of gynecological malignancies.
    DiSaia PJ
    J Reprod Med; 1975 Jan; 14(1):17-20. PubMed ID: 1110478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of cell-mediated immunity in women with genital tract cancer to origin, histology, clinical stage and subsequent behaviour of neoplasm.
    Khoo SK; Mackay EV
    J Obstet Gynaecol Br Commonw; 1974 Mar; 81(3):229-35. PubMed ID: 4821482
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoembryonic antigen in malignant and nonmalignant gynecologic tumors: circulating levels and tissue localization.
    Rutanen EM; Lindgren J; Sipponen P; Stenman UP; Saksela E; Seppäla M
    Cancer; 1978 Aug; 42(2):581-90. PubMed ID: 354771
    [No Abstract]   [Full Text] [Related]  

  • 12. Immuno-histological localization of tissue polypeptide antigen (TPA) in gynecological malignancies.
    Ikarashi T; Takeuchi S; Sudo N; Ueda M; Furuya M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2117-20. PubMed ID: 3908587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of HL-A antigens and lymphocytes in choriocarcinoma and hydatidiform mole pregnancy].
    Tamás K; Gabriella K; Ildikó P; László K
    Orv Hetil; 1976 Oct; 117(41):2478-80. PubMed ID: 135239
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinoembryonic antigen in cancer of the female reproductive system. Serial plasma values correlated with disease state.
    DiSaia PJ; Morrow CP; Haverback BJ; Dyce BJ
    Cancer; 1977 Jun; 39(6):2365-70. PubMed ID: 194665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated antigens in gynecologic cancer.
    DiSaia PJ
    Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HLA-SD-antigens in cervix cancer and recurrent herpes genitalis patients (author's transl)].
    Dostal V; Mayr WR
    Osterr Z Onkol; 1977; 3(5-6):119-21. PubMed ID: 193077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged survival in bronchogenic carcinoma associated with HL-A antigens W-19 and HL-A5: a preliminary report.
    Dellon AL; Rogentine GN; chretien PB
    J Natl Cancer Inst; 1975 Jun; 54(6):1283-6. PubMed ID: 1133845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
    Ueda G; Inoue Y; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Saito J; Nishino T; Abe Y
    Int J Gynecol Pathol; 1984; 3(3):291-8. PubMed ID: 6389386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
    Bhattacharya M; Barlow JJ
    Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinoembryonic antigen in patients with squamous cell carcinoma of the cervix uteri and vulva.
    DiSaia P; Haverback BJ; Dyce BJ; Morrow M
    Surg Gynecol Obstet; 1974 Apr; 138(4):542-4. PubMed ID: 4205815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.